Trilogy Capital’s Palantir PLTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18M Buy
96,066
+32,602
+51% +$5.2M 0.69% 33
2026
Q2
$7.4M Buy
63,464
+37,185
+142% +$5.07M 0.29% 64
2026
Q1
$3.84M Buy
26,279
+19,303
+277% +$2.95M 0.17% 97
2025
Q4
$1.24M Buy
6,976
+2,895
+71% +$524K 0.06% 170
2025
Q3
$744K Sell
4,081
-2,265
-36% -$367K 0.03% 204
2025
Q2
$865K Buy
6,346
+282
+5% +$33.1K 0.04% 187
2025
Q1
$512K Buy
6,064
+1,701
+39% +$149K 0.03% 222
2024
Q4
$330K Buy
+4,363
New +$254K 0.02% 270

Other funds holding PLTR

Trilogy Capital's PLTR Position: Q3 2026 in Review

Trilogy Capital increased its Palantir (PLTR) stake by 51% in Q3 2026, buying an estimated $5.2M and bringing the position to 96,066 shares worth $18M. The position accounts for 0.69% of the portfolio, ranked #33.

Trilogy Capital first reported a position in PLTR in Q4 2024 and has held it in 8 quarters since. 727 funds tracked by Wall St. Rank hold PLTR as of Q3 2026.

  • Trilogy Capital held 96,066 shares of Palantir worth $18M as of Q3 2026.
  • Trilogy Capital bought 32,602 Palantir shares in Q3 2026, an estimated $5.2M.
  • Palantir made up 0.69% of Trilogy Capital's portfolio in Q3 2026, its #33 holding.
  • Trilogy Capital first reported a position in Palantir in Q4 2024 and has held it in 8 quarters since.
  • 727 funds tracked by Wall St. Rank held Palantir as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.